tiprankstipranks
Trending News
More News >
Mersana Therapeutics Inc (MRSN)
NASDAQ:MRSN
US Market

Mersana Therapeutics (MRSN) Cash flow

Compare
698 Followers

Mersana Therapeutics Cash Flow

MRSN's free cash flow for Q3 2025 was $-3.19M. For the 2025 fiscal year, MRSN's free cash flow was decreased by $88.58M and operating cash flow was $-3.19M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -82.34M$ -168.88M$ -49.36M$ -139.99M$ -74.70M
Investing Cash Flow
$ 11.44M$ 119.88M$ -152.72M$ -648.00K$ 37.03M
Financing Cash Flow
$ 4.09M$ 94.67M$ 153.02M$ 63.65M$ 230.41M
End Cash Position
$ 108.23M$ 175.04M$ 129.36M$ 178.43M$ 255.41M
Free Cash Flow
$ -82.47M$ -171.05M$ -51.56M$ -140.64M$ -75.17M
Currency in USD

Mersana Therapeutics Cash Flow